About Chelsea Therapeutics International (NASDAQ:CHTP)
Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson's Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome. In addition, the Company is developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis and is exploring potential applications in multiple other autoimmune disorders.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Chelsea Therapeutics International (NASDAQ:CHTP) Frequently Asked Questions
What is Chelsea Therapeutics International's stock symbol?
Chelsea Therapeutics International trades on the NASDAQ under the ticker symbol "CHTP."
Who are some of Chelsea Therapeutics International's key competitors?
Some companies that are related to Chelsea Therapeutics International include Apple (AAPL), Alphabet (GOOGL), Alphabet (GOOG), Amazon.com (AMZN), Microsoft (MSFT), Facebook (FB), Intel (INTC), Cisco Systems (CSCO), Comcast (CMCSA), PepsiCo (PEP), Netflix (NFLX), Nvidia (NVDA), Amgen (AMGN), Adobe Systems (ADBE), Booking (BKNG), Texas Instruments (TXN), Broadcom (AVGO) and Gilead Sciences (GILD).
Has Chelsea Therapeutics International been receiving favorable news coverage?
Media coverage about CHTP stock has trended somewhat positive this week, Accern reports. Accern rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Chelsea Therapeutics International earned a media sentiment score of 0.16 on Accern's scale. They also assigned press coverage about the healthcare company an impact score of 44.54 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of Chelsea Therapeutics International?
Shares of CHTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Chelsea Therapeutics International?
Chelsea Therapeutics International's mailing address is 3530 Toringdon Way Ste 200, CHARLOTTE, NC 28277-3436, United States. The healthcare company can be reached via phone at +1-704-3411516.
MarketBeat Community Rating for Chelsea Therapeutics International (CHTP)MarketBeat's community ratings are surveys of what our community members think about Chelsea Therapeutics International and other stocks. Vote "Outperform" if you believe CHTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHTP will underperform the S&P 500 over the long term. You may vote once every thirty days.
Chelsea Therapeutics International (NASDAQ:CHTP) Analyst Ratings History
(Data available from 4/23/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Chelsea Therapeutics International (NASDAQ:CHTP) Earnings History and Estimates Chart
Chelsea Therapeutics International (NASDAQ CHTP) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Chelsea Therapeutics International (NASDAQ:CHTP) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Chelsea Therapeutics International (NASDAQ CHTP) Insider Trading and Institutional Ownership History
Chelsea Therapeutics International (NASDAQ CHTP) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Chelsea Therapeutics International (NASDAQ CHTP) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Chelsea Therapeutics International (NASDAQ:CHTP) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Chelsea Therapeutics International (NASDAQ:CHTP) Income Statement, Balance Sheet and Cash Flow Statement
Chelsea Therapeutics International (NASDAQ CHTP) Stock Chart for Monday, April, 23, 2018